Bruno Junior Neves
Overview
Explore the profile of Bruno Junior Neves including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Costa V, Motta F, Dos Santos Carvalho A, Mendonca de Melo F, Mottin M, Charneau S, et al.
J Chem Inf Model
. 2025 Feb;
65(5):2636-2649.
PMID: 40007463
Chagas disease remains a persistent public health challenge due to the limited efficacy and significant toxicity of current pharmacological treatments. This highlights the urgent need for novel drugs with innovative...
2.
Contreras Colmenares M, de Oliveira Matos A, Henrique Dos Santos Dantas P, Rodrigues do Carmo Neto J, Neves B, Gardinassi L, et al.
ACS Omega
. 2025 Feb;
10(5):4881-4895.
PMID: 39959083
Norovirus (NoV) is a major cause of acute diarrheal disease in humans. However, due to complications in cultivating this virus, bioinformatics aids in elucidating the virus-host relationship. One of the...
3.
de Almeida Santos E, Lemos J, Dos Santos Carvalho A, Mendonca de Melo F, Pereira E, Moreira-Filho J, et al.
ACS Omega
. 2025 Jan;
9(52):51271-51284.
PMID: 39758621
Visceral leishmaniasis caused by is a severe and often fatal disease prevalent in low- and middle-income countries. Existing treatments are hampered by toxicity, high costs, and the emergence of drug...
4.
Borges K, Kipnis A, Neves B, Junqueira-Kipnis A
Curr Drug Targets
. 2024 Sep;
25(14):971-986.
PMID: 39225221
is a globally disseminated Gram-negative bacterium that causes several types of serious nosocomial infections, the most worrisome being ventilator-associated pneumonia and bacteremia related to using venous catheters. Due to its...
5.
Santos A, Costa V, Freitas V, Dos Anjos L, de Almeida Santos E, Arantes T, et al.
Braz J Microbiol
. 2024 Jul;
55(4):4229.
PMID: 38987525
No abstract available.
6.
Santos A, Costa V, Freitas V, Dos Anjos L, de Almeida Santos E, Arantes T, et al.
Braz J Microbiol
. 2024 Jun;
55(3):2655-2667.
PMID: 38888692
Sporotrichosis is recognized as the predominant subcutaneous mycosis in South America, attributed to pathogenic species within the Sporothrix genus. Notably, in Brazil, Sporothrix brasiliensis emerges as the principal species, exhibiting...
7.
Cassiano G, Martinelli A, Mottin M, Neves B, Andrade C, Ferreira P, et al.
Front Cell Infect Microbiol
. 2024 Mar;
14:1353057.
PMID: 38495651
Introduction: The global evolution of resistance to Artemisinin-based Combination Therapies (ACTs) by malaria parasites, will severely undermine our ability to control this devastating disease. Methods: Here, we have used whole...
8.
de Souza Neto L, Montoya B, Brandao-Neto J, Verma A, Bowyer S, Moreira-Filho J, et al.
Sci Rep
. 2024 Jan;
14(1):1582.
PMID: 38238498
Schistosomiasis is caused by parasites of the genus Schistosoma, which infect more than 200 million people. Praziquantel (PZQ) has been the main drug for controlling schistosomiasis for over four decades,...
9.
Moreira-Filho J, Neves B, Cajas R, de Moraes J, Andrade C
Future Med Chem
. 2023 Nov;
15(22):2033-2050.
PMID: 37937522
The impact of schistosomiasis, which affects over 230 million people, emphasizes the urgency of developing new antischistosomal drugs. Artificial intelligence is vital in accelerating the drug discovery process. We developed...
10.
de Oliveira A, do Carmo Silva L, Neves B, Costa V, Muratov E, Andrade C, et al.
Future Med Chem
. 2023 Sep;
15(17):1553-1567.
PMID: 37727967
The development of safe and effective therapies for treating paracoccidioidomycosis using computational strategies were employed to discover anti- compounds. We 1) collected, curated and integrated the largest library of compounds...